Management Strategies
for Complex
Crohn’s Disease:
Medical vs. Surgical Approach
Management Strategies for
Complex
Crohn’s Disease Case Presentations
Release Date: September 24, 2009
Expiration Date: September 24, 2011
 |
||
|
How to Obtain AMA PRA
|
|
 |
||
Estimated Time of Completion: 1 hour 30 minutes
Description
The Management Strategies for Complex Crohn’s Disease: Medical vs. Surgical Approach Webcast Series was filmed in front of a live audience during a satellite symposium at the Digestive Disease Week. This series presents in-depth clinical perspectives on the advantages and disadvantages of surgical and medical treatment of Crohn’s disease in a case-based format. It also highlights major strategies for when and how medical versus surgical therapy should be instituted.
Objectives
After completing this activity, the participant will be able to do the following:
- Discuss heterogeneity in clinical presentation and manifestation of Crohn’s disease.
- Review the diagnosis and surgical and medical therapy for Crohn’s disease.
- Design a team approach for a patient with complex Crohn’s disease using gastroenterologists, colorectal surgeons, GI pathologists, and GI radiologists.
- Explain the challenges and complexity of Crohn’s disease.
Target Audience
This webcast is directed to gastroenterologists, colorectal surgeons, primary care internists, family practitioners, nurses, nurse practitioners, and other associated health care professionals who treat inflammatory bowel disease and Crohn’s disease and who want to understand the full range of treatment options, with associated advantages and disadvantages.
Accreditation
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.
Activity Director
| Bo Shen, MD Department of Gastroenterology Digestive Disease Institute Cleveland Clinic Cleveland, OH |
Feza H. Remzi, MD Chairman, Department of Colorectal Surgery Digestive Disease Institute Cleveland Clinic Cleveland, OH |
Faculty
| Victor W. Fazio, MD, MS Chairman, Digestive Disease Institute Department of Colorectal Surgery Cleveland Clinic Cleveland, OH |
Brian G. Feagan, MD Professor of Medicine Professor of Epidemiolog y& Biostatistics Robarts Research Institute University of Western Ontario London, ON |
| Bret A. Lashner, MD, MPH Professor of Medicine Department of Gastroenterology Digestive Disease Institute Cleveland Clinic Cleveland, OH |
Scott A. Strong, MD Department of Colorectal Surgery Digestive Disease Institute Cleveland Clinic Cleveland, OH |
Faculty Disclosure
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:
| Victor W. Fazio, MD, MS | |||
| Teaching and Speaking: | Genzyme | ||
| Brian G. Feagan, MD | |||
| Board Membership, Consulting, Teaching & Speaking: | UCB | ||
| Consulting: | Biogen Idec; Millennium | ||
| Consulting, Teaching & Speaking: | Abbott Laboratories; Schering-Plough Canada | ||
| Bret A. Lashner, MD, MPH | |||
| Teaching & Speaking, Review Panels: | Abbott Laboratories; Elan; P&G; Prometheus; Salix; Shire; UCB | ||
| Feza H. Remzi, MD | |||
| Teaching and Speaking: | Covidien | ||
| Bo Shen, MD | |||
| Consulting: | Abbott | ||
| Consulting, Research: | Salix; UCB | ||
| Research: | Ocera Therapeutics | ||
The Cleveland Clinic Foundation Center for Continuing Education acknowledges education grants
for partial support of this activity from the following:
Abbott Laboratories,
UCB
This CME activity was produced by The Cleveland Clinic Foundation
Center for Continuing Education, the Digestive Disease Institute and UNITECH Communications®.
